Medtech Insights

The European CMF device market will grow moderately through 2023 as rising procedure volumes—due to favorable demographics—and the increasing use of premium-priced products offset market…

The Latin American market for facial injectables will face somewhat limited procedure volume growth in the short term due to poor economic conditions. However, given the high levels of…

The European varicose vein treatment device market remains underpenetrated and will see growth driven by the increasing adoption of minimally invasive procedures; the endovenous ablation market is…

As health care organizations progress toward value-based health care, the US market for enterprise solutions is evolving into a lucrative space where favorable regulatory structures and the…

Enduring economic uncertainty in Europe, further compounded by the Brexit vote in the UK, has created an unfavorable environment for the sale of expensive surgical navigation systems. As a result,…

The European CABG device market consists of sales of ONCAB, OPCAB, EVH, and anastomosis assist devices used for surgical revascularization for CAD patients; ONCABdevices are also employed…

The European CMF device market will grow moderately through 2025 as a result of favorable demographics and advancements in technology. Additionally, the increasing use of premium-priced products…

Budget and sustainability challenges faced by health care facilities, as well as the rising acceptance of reprocessing among OEMs and physicians will support growth in the overall US market for…

Expansion of the Japanese GI endoscopy device market will be driven by a high incidence of gastric cancer and broad coverage for CRC screening in the country; however, reimbursement cuts and and a…

The US CMF device market will grow at a moderate pace through 2025, primarily as a result of favorable demographics, increasing penetration into existing eligible patient populations, an ongoing…

The US EP mapping and ablation device market will experience strong growth through 2024, particularly in the diagnostic and ablation catheter segments, largely as a result of rising ablation…

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by…